Comparison
3p Syndrome C4706503 vs 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
Clinical comparison between 3P Syndrome and 17 Alpha Hydroxylase 7 20 Lyase Deficiency CN380063 for differential diagnosis and treatment planning.
3p Syndrome C4706503
A rare chromosomal disorder involving deletion of genetic material from chromosome 3. It causes distinctive facial features, growth delays, and intellectual disability. Care involves managing developmental and medical complications.
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
A rare genetic disorder affecting steroid hormone production. Causes ambiguous genitalia, lack of puberty, and high blood pressure. Requires lifelong hormone replacement therapy.
6 comparison axes
Onset
3p Syndrome C4706503
0-0
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
0-18
Onset patterns differ
Severity
3p Syndrome C4706503
severe
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
severe
Different severity levels
Chronic
3p Syndrome C4706503
Chronic
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
Chronic
Differing course
Communicable
3p Syndrome C4706503
No
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
No
Different transmission
Body System
3p Syndrome C4706503
congenital
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
Same/different system
Category
3p Syndrome C4706503
genetic
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
Different category
Bottom line
3p-syndrome-C4706503 and 17-alpha-hydroxylase-7-20-lyase-deficiency-CN380063 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3p Syndrome C4706503 | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Growth delay and intellectual disability are described as core features. | Pubertal delay is described; intellectual disability is not established by the source. | High |
| Genital and pubertal findings | Not a defining feature in the supplied description. | Ambiguous genitalia and absent puberty are described. | High |
| Blood pressure | Hypertension is not established by the source. | High blood pressure is a described feature. | Moderate |
When to favor each condition
Choose 3p Syndrome C4706503 when
Congenital dysmorphic and developmental presentation
Facial features, growth delay, and intellectual disability point toward a chromosomal disorder.
Moderate
Suspected chromosomal deletion
The source identifies deletion of material from chromosome 3.
High
Need for developmental complication management
Care centers on developmental and medical complications rather than steroid replacement.
Moderate
Choose 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 when
Disordered puberty or ambiguous genitalia
These findings are specifically described for the steroid-synthesis disorder.
High
Hypertension with endocrine features
High blood pressure accompanies impaired steroid hormone production in the source.
Moderate
Need for lifelong hormone therapy
The source states that hormone replacement is required long term.
High
How key tests differ
| Test | 3p Syndrome C4706503 | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | Interpretation |
|---|---|---|---|
| Chromosomal analysis | May identify deletion involving chromosome 3. | Not expected to establish this endocrine diagnosis. | A chromosomal finding supports 3p syndrome but requires specialist confirmation. |
| Steroid hormone profile | No characteristic steroid pattern is established here. | Abnormal steroid production is expected, without a universal cutoff supplied. | Interpret results as laboratory abnormalities pending endocrine diagnosis. |
| Targeted genetic testing | May support a chromosomal diagnosis when clinically indicated. | May identify the causative steroid-enzyme gene variant. | Genetic results should be correlated with phenotype by a clinician. |
Prognosis comparison
3p Syndrome C4706503
- Outcome
- Chronic course with developmental and medical complications; exact prognosis is not established.
- Factors
- Extent of chromosomal deletion and associated complications may influence needs.
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
- Outcome
- Chronic endocrine disorder requiring lifelong hormone replacement; exact prognosis is not established.
- Factors
- Hormone deficiency, puberty, blood pressure, and treatment adherence may matter.
Time frame: Left is congenital; right may present from birth through adolescence.
Neither mortality nor treatment response can be quantified from the source.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Growth and intellectual disability may require ongoing support. Not established as core complications by the source. Individual needs vary and should be assessed clinically. |
| Pubertal and sexual development | Not specifically established in the source. Absent puberty and ambiguous genitalia are described. Endocrine and psychosocial care may be needed. |
| Blood-pressure effects | Not established by the supplied description. Hypertension is described and may need monitoring. No treatment dose or outcome rate is established here. |
Patient education highlights
- HighDifferent causes
One condition involves chromosome 3 deletion; the other impairs steroid hormone production.
- HighSpecialist follow-up
Genetics, developmental, or endocrine specialists should guide testing and care.
- MediumLifelong planning
Both are chronic; the endocrine disorder specifically requires ongoing hormone replacement.